ClinicalTrials.Veeva

Menu

Low Impact Laparoscopy Concept Versus Conventional Laparoscopy (RANDOLIL)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Terminated

Conditions

Ambulatory Laparoscopic Hysterectomy

Treatments

Other: post-operative questionnaire
Other: Saint-Antoine Pain Questionnaire (QDSA)
Device: Low Impact Laparoscopy
Device: conventional laparoscopy
Other: Visual Analog Scale (VAS) for Pain

Study type

Interventional

Funder types

Other

Identifiers

NCT04165148
69HCL19_0335
2019-A01863-54 (Other Identifier)

Details and patient eligibility

About

Outpatient surgical management has been developing in recent years and High Authority of Health recommendations in French for this type of management is a postoperative pain score of less than 3 on the VAS.

The feasibility and safety of laparoscopy is well established, particularly in the field of gynecology, but this technique often causes postoperative pain. Techniques are being developed to reduce postoperative pain in laparoscopic surgery. Low pressure insufflation (7 to 10 mmHg) compared to standard pressure insufflation (12 to 15 mmHg) significantly reduces postoperative pain. Microcoelioscopy (use of 3 mm trocars instead of 5 to 12 mm trocars in standard laparoscopy), by reducing the size of incisions, also significantly reduces postoperative pain.

The Low Impact Laparoscopy is a minimally invasive technique that combines low pressure insufflation and microcoelioscopy which would have the advantage of reducing postoperative pain. This technique would therefore, by reducing postoperative pain, to improve outpatient management, particularly in cases of hysterectomies for which the outpatient management rate could be increased.

The hypothesis is that using the Low Impact Laparoscopy concept would increase outpatient management rate compared to conventional laparoscopy in gynecological surgeries for hysterectomy.

The study aims to compare the Low Impact Laparoscopy concept with conventional laparoscopy in terms of ambulatory care rates in patients undergoing surgery for hysterectomy.

Enrollment

2 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women over 18 years
  • planned surgery procedure : ambulatory laparoscopic hysterectomy
  • effective contraception if women of childbearing age
  • patients with free, informed and signed consent

Exclusion criteria

  • disorders leading to an unacceptable risk of postoperative complications sought during the interrogation of the patient (disorders of blood coagulation, disorders of the immune system, progressive diseases ....)
  • pregnancy or wish for subsequent pregnancy
  • lactating women
  • contraindication to laparoscopy
  • contraindication to minimally invasive endoscopic techniques
  • not eligible for outpatient care
  • inability to understand the information given
  • a person not affiliated to a social security scheme, or deprived of liberty, or under guardianship.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2 participants in 2 patient groups

Low Impact Laparoscopy
Experimental group
Description:
Low Impact Laparoscopy is a minimally invasive technique that combines low pressure insufflation (with the Intelligent Flow System (iFS) AirSeal® system) and microcoelioscopy (with specific microtrocards and laparoscopic instruments).
Treatment:
Other: post-operative questionnaire
Other: Visual Analog Scale (VAS) for Pain
Device: Low Impact Laparoscopy
Other: Saint-Antoine Pain Questionnaire (QDSA)
conventional laparoscopy
Active Comparator group
Description:
conventional laparoscopy
Treatment:
Other: post-operative questionnaire
Other: Visual Analog Scale (VAS) for Pain
Other: Saint-Antoine Pain Questionnaire (QDSA)
Device: conventional laparoscopy

Trial contacts and locations

1

Loading...

Central trial contact

Gery LAMBLIN, PU,PH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems